Cargando…

Comparative efficacy and safety of mizoribine and mycophenolate mofetil for treating systemic lupus erythematosus: a retrospective cohort study

BACKGROUND: Mizoribine (MZR) is an immunosuppressive agent that selectively inhibits inosine monophosphate dehydrogenase; its actions are considerably similar to those of mycophenolate mofetil (MMF). This study aimed to clarify whether MZR can be a good treatment option for systemic lupus erythemato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayano, Masahiro, Kimoto, Yasutaka, Mitoma, Hiroki, Akahoshi, Mitsuteru, Ono, Nobuyuki, Arinobu, Yojiro, Akashi, Koichi, Horiuchi, Takahiko, Niiro, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9109492/ https://www.ncbi.nlm.nih.gov/pubmed/35586513 http://dx.doi.org/10.1177/1759720X221096367

Ejemplares similares

Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
por: Nakano, Miki, et al.
Publicado: (2021)

Increased Proportion of CD226(+) B Cells Is Associated With the Disease Activity and Prognosis of Systemic Lupus Erythematosus
por: Nakano, Miki, et al.
Publicado: (2021)

Autoimmune manifestations associated with myelodysplastic syndrome predict a poor prognosis
por: Arinobu, Yojiro, et al.
Publicado: (2021)

CD34-selected versus unmanipulated autologous haematopoietic stem cell transplantation in the treatment of severe systemic sclerosis: a post hoc analysis of a phase I/II clinical trial conducted in Japan
por: Ayano, Masahiro, et al.
Publicado: (2019)

Methotrexate Enhances Apoptosis of Transmembrane TNF-Expressing Cells Treated With Anti-TNF Agents
por: Wang, Qiaolei, et al.
Publicado: (2020)

Effects of tumor necrosis factor inhibitors and tocilizumab on the glycosylated hemoglobin levels in patients with rheumatoid arthritis; an observational study
por: Otsuka, Yukimi, et al.
Publicado: (2018)

Transient Antiphospholipid Syndrome Associated with Primary Cytomegalovirus Infection: A Case Report and Literature Review
por: Nakayama, Tsuyoshi, et al.
Publicado: (2014)

HLA-B52 allele in giant cell arteritis may indicate diffuse large-vessel vasculitis formation: a retrospective study
por: Kushimoto, Kazuo, et al.
Publicado: (2021)

CEACAM 1, 3, 5 and 6 -positive classical monocytes correlate with interstitial lung disease in early systemic sclerosis
por: Yokoyama, Kana, et al.
Publicado: (2022)

Serum progranulin levels are elevated in dermatomyositis patients with acute interstitial lung disease, predicting prognosis
por: Tanaka, Atsushi, et al.
Publicado: (2015)

CCR6+ group 3 innate lymphoid cells accumulate in inflamed joints in rheumatoid arthritis and produce Th17 cytokines
por: Takaki-Kuwahara, Ayako, et al.
Publicado: (2019)

Human PD-1(hi)CD8(+) T Cells Are a Cellular Source of IL-21 in Rheumatoid Arthritis
por: Higashioka, Kazuhiko, et al.
Publicado: (2021)

Association of circulating SLAMF7(+)Tfh1 cells with IgG4 levels in patients with IgG4-related disease
por: Higashioka, Kazuhiko, et al.
Publicado: (2020)

Serum progranulin levels are elevated in patients with systemic lupus erythematosus, reflecting disease activity
por: Tanaka, Atsushi, et al.
Publicado: (2012)

Mycophenolate mofetil use in refractory juvenile systemic lupus erythematosus
por: Marques, R, et al.
Publicado: (2010)

Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
por: Falcini, FF, et al.
Publicado: (2008)

Mycophenolate Mofetil for Systemic Lupus Erythematosus: Our 20-Year Experience
por: Trevisonno, Michael, et al.
Publicado: (2023)

The Efficacy and Safety of Mizoribine versus Mycophenolate Mofetil for the Treatment of Renal Transplantation: A Systematic Review and Meta-Analysis
por: Chen, Jie, et al.
Publicado: (2022)

Mycophenolate mofetil in the treatment of lupus nephritis
por: Yong, Patrick FK, et al.
Publicado: (2008)

Bullous Systemic Lupus Erythematosus Successfully Treated With Intravenous Immunoglobulin and Mycophenolate Mofetil
por: Chow, Kevin W, et al.
Publicado: (2023)

Successful Treatment of Refractory Thrombocytopenia with Mycophenolate Mofetil in a Patient with Systemic Lupus Erythematosus
por: Chang, Hyun Kyu
Publicado: (2005)

Successful Treatment of Mucocutaneous Lupus Erythematosus in a Dog with Prednisolone, Mycophenolate Mofetil and Tacrolimus
por: Hyun, Jae-Eun, et al.
Publicado: (2021)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Differential effects of cyclophosphamide and mycophenolate mofetil on cellular and serological parameters in patients with systemic lupus erythematosus
por: Fassbinder, Till, et al.
Publicado: (2015)

Development and validation of limited sampling strategy equation for mycophenolate mofetil in children with systemic lupus erythematosus
por: Prabha, R., et al.
Publicado: (2016)

Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension
por: Machireddy, Kirthi, et al.
Publicado: (2018)

The Effect of Mycophenolate Mofetil on Non-Renal Manifestations in Systemic Lupus Erythematosus: Results from Korean Lupus Network Registry
por: Jung, Ui Hong, et al.
Publicado: (2019)

Neuropsychiatric Systemic Lupus Erythematosus with Cerebral Vasculitis and Lupus Nephritis Successfully Treated with High-dose Glucocorticoids and Mycophenolate Mofetil
por: Tanaka, Saki, et al.
Publicado: (2022)

Complement as a Biomarker for Systemic Lupus Erythematosus
por: Ayano, Masahiro, et al.
Publicado: (2023)

Use of mycophenolate mofetil (MMF) in lupus nephritis (LN) in children
por: Indaco, R, et al.
Publicado: (2008)

Treatment of Class IV Lupus Nephritis with Mycophenolate Mofetil Monotherapy
por: Nawata, Takashi, et al.
Publicado: (2018)

Mycophenolate Mofetil Use in Severe Myocarditis Complicating Systemic Lupus
por: Allaoui, Abire, et al.
Publicado: (2022)

Successful Treatment of Systemic Sclerosis-related Pericarditis with Mycophenolate Mofetil and Low-dose Prednisolone
por: Higashioka, Kazuhiko, et al.
Publicado: (2022)

Generation mechanism of RANKL(+) effector memory B cells: relevance to the pathogenesis of rheumatoid arthritis
por: Ota, Yuri, et al.
Publicado: (2016)

A Case of Minimal Change Disease Treated Successfully with Mycophenolate Mofetil in a Patient with Systemic Lupus Erythematosus
por: Hong, Young Hoon, et al.
Publicado: (2011)

Management of mycophenolate mofetil-induced acne in patients with Systemic Lupus Erythematosus: report of four cases and review of the literature
por: Perricone, Carlo, et al.
Publicado: (2018)

PK/PD Study of Mycophenolate Mofetil in Children With Systemic Lupus Erythematosus to Inform Model-Based Precision Dosing
por: Chen, Yewei, et al.
Publicado: (2020)

Successful Treatment with Mycophenolate Mofetil and Tacrolimus in Juvenile Severe Lupus Nephritis
por: Kise, Tomoo, et al.
Publicado: (2015)

Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis
por: Rezaieyazdi, Zahra, et al.
Publicado: (2014)

The Effect of Mycophenolate Mofetil on Disease Development in the gld.apoE (−/−) Mouse Model of Accelerated Atherosclerosis and Systemic Lupus Erythematosus
por: Richez, Christophe, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ssujpmkbn4j19tnp327eaqsl7j